Journals / Turkish Journal of Hematology / 2015 / Cilt: 32 - Sayı: 1

İnvaziv Pulmoner Aspergillozise Bağlı Masif Hemoptizi Görülen Adölesan Bir Hastada, Endikasyon Dışı Rekombinan Faktör VIIa nın ve Coil Emobolizasyonunun Başarılı Kullanımı

Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis

Pages
73–76
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we describe a patient with massive hemoptysis due to invasive pulmonary aspergillosis whose bleeding was controlled successfully with off-label use of recombinant factor VIIa and subsequent coil embolization of the right pulmonary artery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Abstract: Invasive fungal infections have turned out to be a significant cause of morbidity and mortality in pediatric patients with malignant disorders.
📊
Key Findings & Data:Massive hemoptysis, a rare complication of invasive pulmonary aspergillosis, may threaten the lives of patients, usually during the resolution of neutropenia.
💡
Conclusion & Impact:In this report, we describe a patient with massive hemoptysis due to invasive pulmonary aspergillosis whose bleeding was controlled successfully with off-label use of recombinant factor VIIa and subsequent coil embolization of the right pulmonary artery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Abstract: Invasive fungal infections have turned out to be a significant cause of morbidity and mortality in pediatric patients with malignant disorders. Massive hemoptysis, a rare complication of invasive pulmonary aspergillosis, may threaten the lives of patients, usually during the resolution of neutropenia. In this report, we describe a patient with massive hemoptysis due to invasive pulmonary aspergillosis whose bleeding was controlled successfully with off-label use of recombinant factor VIIa and subsequent coil embolization of the right pulmonary artery. Key Words:

Özet

İnvaziv fungal enfeksiyonlar pediatrik malin hastalıklarda morbidite ve mortalitenin önemli bir nedenidir. Masif hemoptizi de sıklıkla nötropenin düzelme aşamasında görülen, invaziv pulmoner aspergillozisin hayatı tehdit edici nadir bir komplikasyonudur. Bu yazıda invaziv pulmoner aspergillozise bağlı masif hemoptizi gelişen bir hastada endikasyon dışı recombinant FVIIa kullanımı ardından sağ pulmoner artere coil embolizasyon uygulanarak kanama kontrolu sağlanan bir olgu sunulmuştur. Anahtar Sözcükler:

🔖

Cite This Article

GÖKÇEBAY, D. G., FETTAH, A., KIRBAŞ, İ., TUNÇ, B., ÖZBEK, N. Y. (2015). İnvaziv Pulmoner Aspergillozise Bağlı Masif Hemoptizi Görülen Adölesan Bir Hastada, Endikasyon Dışı Rekombinan Faktör VIIa nın ve Coil Emobolizasyonunun Başarılı Kullanımı. Turkish Journal of Hematology, Cilt: 32 - Sayı: 1, 73–76. https://ajindex.com/articles/412505

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:56-93
  2. Azap A, Bozkurt GY, Yüksel MK, Kutlu H, Topçuoğlu P, Aypak A, Akan H. Secondary infections in cancer patients with febrile neutropenia. Turk J Hematol 2012;29:254-258. 3. de Pauw BE, Viscoli C. Managing invasive fungal infections: relying on clinical instincts or on a rational navigation system? J Antimicrob Chemother 2011;66:55-58
  3. Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Am Rev Respir Dis 1985;131:115- 120
  4. Avci Z, Alioglu B, Anuk D, Ozbek OY, Azap OK, Ozbek N. Double invasive fungal infection and typhlitis in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 2008;25:99-106
  5. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-147
  6. Johnson JL. Manifestations of hemoptysis. Postgrad Med 2002;112:101-106
  7. Yoon W. Embolic agents used for bronchial artery embolization in massive haemoptysis. Expert Opin Pharmacother 2004;5:361-367
  8. Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med 2000;28:1642-1647
  9. Pagano L, Ricci P, Nosari A, Tonso A, Buelli M, Montillo M, Cudillo L, Cenacchi A, Savignana C, Melillo L. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell’Adulto). Br J Haematol 1995;89:500-505. 11.Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-805
  10. Lordon JL, Gascoigne A, Corris PA. The pulmonary physician in critical care • Illustrative case 7: assessment and management of massive haemoptysis. Thorax 2003;58:814- 819
  11. Bain J, Lewis D, Bernard A, Hatton K, Reda H, Flynn J. Implementation of an off-label recombinant factor VIIa protocol for patients with critical bleeding at an academic medi